tiprankstipranks
Trending News
More News >
Xylo Technologies Ltd (XYLO)
NASDAQ:XYLO

Xylo Technologies Ltd (XYLO) AI Stock Analysis

Compare
271 Followers

Top Page

XY

Xylo Technologies Ltd

(NASDAQ:XYLO)

Rating:54Neutral
Price Target:
$5.50
▲(9.13%Upside)
Xylo Technologies Ltd shows significant financial weaknesses, with ongoing losses and liquidity issues weighing heavily on the stock score. While technical indicators suggest moderate bullish momentum, valuation concerns due to negative earnings and lack of dividends further impact the score. Strategic efforts to improve financial health are critical for future performance.

Xylo Technologies Ltd (XYLO) vs. SPDR S&P 500 ETF (SPY)

Xylo Technologies Ltd Business Overview & Revenue Model

Company DescriptionXylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops wireless vehicle battery charging technologies and modular electronic vehicles. The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024. Xylo Technologies Ltd was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.
How the Company Makes MoneyXylo Technologies Ltd generates revenue through a diversified portfolio of technology-driven services and products. The company's primary revenue streams include subscription-based software-as-a-service (SaaS) offerings, customized enterprise solutions, and cloud computing services. Additionally, XYLO earns significant income from consulting and implementation services, helping businesses integrate and optimize their digital infrastructures. Strategic partnerships with leading technology firms enhance XYLO's market reach and product offerings, while ongoing investments in research and development ensure a steady pipeline of innovative solutions that meet evolving customer needs. The company also capitalizes on data analytics and cybersecurity services, which are increasingly in demand as organizations prioritize data-driven decision-making and robust security measures.

Xylo Technologies Ltd Financial Statement Overview

Summary
Overall, Xylo Technologies Ltd is grappling with significant financial challenges across its income statement, balance sheet, and cash flow. The company struggles with profitability, despite revenue growth, and faces cash flow issues that could impact its ability to sustain operations. While its debt position is not critically high, declining equity and persistent losses pose long-term financial risks.
Income Statement
28
Negative
Xylo Technologies Ltd has faced significant challenges in maintaining profitability, as indicated by its negative EBIT and net income over multiple years. Although revenue has increased substantially since 2019, gross profit margins remain low or negative, suggesting cost control issues. The lack of positive revenue growth in the most recent year compounds these concerns.
Balance Sheet
55
Neutral
The balance sheet shows a moderate level of financial stability with a debt-to-equity ratio that is manageable, supported by a relatively higher equity ratio. However, the decline in stockholders' equity over recent years highlights potential vulnerabilities. While the company's total liabilities have increased over the years, the debt levels are not excessively high, which provides some comfort.
Cash Flow
40
Negative
The cash flow statement reveals persistent negative operating cash flow and free cash flow, indicating financial strain. The company's ability to convert operating profits into cash is weak, as evidenced by negative free cash flow to net income ratios. The growth of free cash flow is also negative, highlighting ongoing challenges in cash generation.
Breakdown
TTMDec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Income StatementTotal Revenue
57.64M91.72M91.86M10.12M531.00K273.00K
Gross Profit
7.80M11.84M14.45M4.80M-503.00K-182.00K
EBIT
-17.94M-23.32M-8.58M-8.20M-7.46M-4.20M
EBITDA
-5.20M-16.30M-5.38M6.99M-7.30M-13.89M
Net Income Common Stockholders
-15.99M-16.02M-9.81M6.79M-4.33M-14.18M
Balance SheetCash, Cash Equivalents and Short-Term Investments
25.23M12.54M25.23M27.34M22.36M7.04M
Total Assets
97.65M63.90M97.65M59.73M32.34M13.33M
Total Debt
10.13M9.79M10.13M1.62M107.00K152.00K
Net Debt
-10.12M429.00K-10.12M-22.41M-22.26M-6.88M
Total Liabilities
42.96M31.46M42.96M8.30M6.14M5.20M
Stockholders Equity
39.14M23.58M39.14M49.19M22.96M6.71M
Cash FlowFree Cash Flow
-4.15M-7.99M-5.73M-10.39M-6.47M-2.76M
Operating Cash Flow
-4.11M-6.25M-5.66M-5.25M-6.14M-2.69M
Investing Cash Flow
2.73M-4.06M-4.48M-12.21M-1.60M-917.00K
Financing Cash Flow
-4.27M-524.00K5.41M18.92M22.95M-46.00K

Xylo Technologies Ltd Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price5.04
Price Trends
50DMA
5.13
Negative
100DMA
4.82
Positive
200DMA
4.16
Positive
Market Momentum
MACD
0.01
Positive
RSI
46.72
Neutral
STOCH
45.74
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For XYLO, the sentiment is Neutral. The current price of 5.04 is below the 20-day moving average (MA) of 5.19, below the 50-day MA of 5.13, and above the 200-day MA of 4.16, indicating a neutral trend. The MACD of 0.01 indicates Positive momentum. The RSI at 46.72 is Neutral, neither overbought nor oversold. The STOCH value of 45.74 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for XYLO.

Xylo Technologies Ltd Risk Analysis

Xylo Technologies Ltd disclosed 79 risk factors in its most recent earnings report. Xylo Technologies Ltd reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 3 New Risks
1.
The report of Gix Internet's independent registered public accounting firm contains an explanatory paragraph regarding substantial doubt about its ability to continue as a going concern, which could prevent it from obtaining new financing on reasonable terms or at all. Q4, 2023
2.
Jeffs' Brands efforts to expand its business into new brands, products, services, technologies and geographic regions will subject it to additional business, legal, financial and competitive risks and may not be successful. Q4, 2023
3.
Gix Internet may not be able to protect its systems, technology, and infrastructure from cyberattacks. Q4, 2023

Xylo Technologies Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (53)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
54
Neutral
$4.15M-28.99%-67.77%66.19%
53
Neutral
$5.14B3.23-45.01%2.85%17.55%-0.69%
49
Neutral
$3.90M-440.77%-1.21%93.72%
48
Neutral
$4.63M-163.47%-100.00%78.91%
42
Neutral
$6.67M-155.20%9.90%94.56%
37
Underperform
$3.52M-120.16%-7.74%93.25%
37
Underperform
$3.28M-496.27%-16.79%-3.69%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
XYLO
Xylo Technologies Ltd
5.04
-0.36
-6.67%
NUWE
Nuwellis
0.93
-8.97
-90.61%
SINT
Sintx Technologies
2.70
-5.12
-65.47%
RSLS
ReShape Lifesciences
4.58
-401.42
-98.87%
VERO
Venus Concept
2.29
-3.65
-61.45%
HSCS
Heart Test Laboratories, Inc.
3.64
-3.15
-46.39%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.